Essential Tremor: Clinical Trials

267 trials for Essential Tremor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

130 completed, 57 recruiting, 29 unknown, 17 terminated. 133 Not applicable, 38 Phase 2, 14 Phase 1, 11 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable133Completed 57, Recruiting 33, Unknown 14, Terminated 8, Active not recruiting 6, Not yet recruiting 5, Withdrawn 5, Enrolling by invitation 3, Suspended 2
Phase 238Completed 22, Recruiting 4, Terminated 4, Unknown 3, Withdrawn 3, Not yet recruiting 2
Phase 114Completed 10, Recruiting 3, Not yet recruiting 1
Phase 311Completed 5, Recruiting 2, Withdrawn 2, Terminated 1, Unknown 1
Phase 45Completed 5
Early Phase 14Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Essential Tremor: new trials by email Literature Review of Essential Tremor trials Research Report on Essential Tremor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Encora X1™ in a Real World Observational Study
Encora X1 - Essential Tremor
RecruitingEncora, Inc.10002026-11-012026-11-05
Effects of Microelectrode-based Brain Stimulation in Humans
High Definition Brain Stimulation (HDBS) - Essential Tremor, Parkinsons Disease (PD)
Not applicableRecruitingLund University122026-10-152026-11-03
Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation
Cobenfy KarXT pill (50/20 mg), Placebo - Epilepsy, Essential Tremor
Early Phase 1Not yet recruitingUniversity of Texas Southwestern Medical Center302026-10-012026-07-23
Image-Guided DBS Programming
programming a, programming b - Essential Tremor
Not applicableNot yet recruitingUniversity of Pennsylvania202026-09-012026-08-06
Cerebellar Research in Ultrasound Stimulation
Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox, Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox - Essential Tremor
Not applicableNot yet recruitingKU Leuven602026-06-012026-04-02
Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor
Transcranial temporal interference stimulation, Tremor monitoring through Inertial Measurement Units (IMUs) - Essential Tremor
Not applicableNot yet recruitingUniversity Hospital, Geneva62026-05-262026-05-01
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor
Low Intensity Focused Ultrasound (LIFU) - Essential Tremor
Early Phase 1RecruitingUniversity of California, Los Angeles202026-05-012026-05-20
Neuromodulation Strategies for Treatment-Resistant Essential Tremor Using Chronos™ DBS
Continuous, Continuous + High Frequency Cycling, High Frequency - Essential Tremor
Not applicableNot yet recruitingUniversity of British Columbia52026-04-012025-12-24
Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor
Low-Intensity Focused Ultrasound (LIFU) - NeuroFUS PRO - Essential Tremor (ET)
Phase 1 / Phase 2Not yet recruitingUniversity of Sao Paulo General Hospital202026-03-172026-03-19
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
Phoneme sequence learning, Cessation and re-enabling of stimulation of the STN, Cessation and re-enabling of stimulation of the VIM thalamic nucleus - Parkinson's Disease (PD), Essential Tremor
Not applicableRecruitingBoston University Charles River Campus802026-02-182026-03-09
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Essential Tremor, Movement Disorders, Essential Tremor
RecruitingCND Life Sciences3002026-02-182026-11-04
Magnetoencephalography (MEG) Pilot Study
MRI and fMRI scans, MEG, Sensor-based motor assessments - Essential Tremor
Not applicableRecruitingUniversity of Florida102026-02-172026-09-30
Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor
Deep Brain Stimulation - Tremor, Essential Tremor
Phase 1RecruitingThe Cleveland Clinic122026-01-152026-07-10
Dual-Site Transcranial Magnetic Stimulation of the Supplementary Motor Area and Cerebellum for the Treatment of Essential Tremor.
Dual-site repetitive transcranial magnetic stimulation (rTMS) of the supplementary motor area and cerebellum, Transcranial Magnetic Stimulation Sham - Essential Tremor
Phase 1 / Phase 2RecruitingSão Paulo State University362026-01-152026-01-21
Non-Invasive Neuromodulation for Essential Tremor: Long-Term Safety and Effectiveness Study
Transcutaneous Afferent Patterned Stimulation - Essential Tremor
Not applicableRecruitingRuijin Hospital502025-12-152026-08-19
LIFUS For Neurological Disorders
LIFUS, Sham LIFUS - Parkinson's Disease (PD), Essential Tremor
Not applicableRecruitingUniversity Health Network, Toronto502025-12-022026-08-13
Analysis of Clinical Outcomes in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Tremor
Essential Tremor, Essential Tremor, Movement Disorders
RecruitingSunnybrook Health Sciences Centre2402025-10-012025-10-08
Attention and Eye Movement in Parkinson's Disease
Normal therapeutic DBS, Reduced current DBS, Reduced frequency DBS - Essential Tremor, Parkinson's Disease (PD)
Not applicableRecruitingUniversity of Nebraska1382025-09-222026-05-05
Proof of Concept Study on BP1.4979 Effect on Essential Tremor
BP1.4979, Placebo - Essential Tremor
Phase 2RecruitingBioprojet502025-09-172025-12-16
Developing a New LIFU Neuromodulation Method to Suppress Tremor
Transcranial focused ultrasound stimulation, Sham stimulation - Essential Tremor
Phase 2Not yet recruitingUniversity of Calgary202025-09-152025-08-05

Showing 20 of 267. Sign in to see all of them.

Narrower conditions

Parkinson Disease (95)  ·  Tremor (45)  ·  Movement Disorders (41)  ·  Dystonia (35)  ·  Parkinsonian Disorders (7)  ·  Dystonic Disorders (6)  ·  Epilepsy (6)  ·  Multiple System Atrophy (6)  ·  Supranuclear Palsy, Progressive (6)  ·  Central Nervous System Diseases (5)  ·  Dyskinesias (5)  ·  Ataxia (4)  ·  Disease (4)  ·  Nervous System Diseases (4)

Broader conditions

Nervous System Diseases (263)  ·  Central Nervous System Diseases (262)  ·  Movement Disorders (226)  ·  Brain Diseases (100)  ·  Basal Ganglia Diseases (97)  ·  Neurodegenerative Diseases (96)  ·  Synucleinopathies (96)  ·  Parkinsonian Disorders (90)  ·  Pathological Conditions, Signs and Symptoms (89)  ·  Signs and Symptoms (87)  ·  Neurologic Manifestations (85)  ·  Dyskinesias (76)  ·  Mental Disorders (14)  ·  Tauopathies (7)  ·  Autonomic Nervous System Diseases (6)

Interventions

Deep Brain Stimulation (17)  ·  1-Octanol (4)  ·  Botulinum Toxins (3)  ·  Propranolol (3)  ·  Transcranial Direct Current Stimulation (3)  ·  Transcranial Magnetic Stimulation (3)  ·  octanoic acid (3)  ·  Botulinum Toxins, Type A (2)  ·  Ethanol (2)  ·  Magnetic Resonance Imaging (2)  ·  Neurofeedback (2)  ·  Pregabalin (2)  ·  Radiosurgery (2)  ·  Surveys and Questionnaires (2)  ·  Ultrasonography (2)

Sponsors

InSightec (13)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (12)  ·  University of Florida (11)  ·  Mayo Clinic (9)  ·  Cala Health, Inc. (5)  ·  University Hospital, Bordeaux (5)  ·  University of Texas Southwestern Medical Center (5)  ·  Abbott Medical Devices (4)  ·  Chinese PLA General Hospital (4)  ·  Praxis Precision Medicines (4)  ·  Sage Therapeutics (4)  ·  The Cleveland Clinic (4)  ·  University of Colorado, Denver (4)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (3)  ·  Aleva Neurotherapeutics SA (3)

Countries

United States (142)  ·  Canada (22)  ·  France (20)  ·  China (13)  ·  Spain (13)  ·  Germany (12)  ·  United Kingdom (10)  ·  Italy (7)  ·  South Korea (7)  ·  Switzerland (7)  ·  Belgium (6)  ·  Taiwan (6)  ·  Austria (5)  ·  Netherlands (5)  ·  Australia (4)

Top investigators

Debra J Ehrlich, M.D. (3)  ·  Mark Hallett, M.D. (3)  ·  Adrian Handforth, M.D. (2)  ·  Ann Marie Murray, MD (2)  ·  Aysegul Gunduz, PhD (2)  ·  Binith Cheeran (2)  ·  Dustin A Heldman, PhD (2)  ·  Emmanuel Flamand-Roze, MD (2)  ·  Francisco A Ponce, MD (2)  ·  Jorge Gonzalez-Martinez, MD, PhD (2)  ·  Kendall Lee, MD, PhD (2)  ·  LongSheng Pan, MD/PhD (2)  ·  Myles Mc Laughlin, Prof. Dr. (2)

Results publications

PMID 35995551, PMID 21594724, PMID 11391740, PMID 12566335, PMID 14718713, PMID 15210907, PMID 17784944, PMID 19452239, PMID 19940187, PMID 20175185, PMID 20201005, PMID 20926368, PMID 21384292, PMID 22454323, PMID 23408867, PMID 23550093, PMID 23944301, PMID 24112892, PMID 26046412, PMID 26881179, PMID 26927672, PMID 27014033, PMID 27231659, PMID 27557301, PMID 27720703, PMID 28007690, PMID 28747452, PMID 30761078, PMID 31244760, PMID 31748250, PMID 32651242, PMID 32815611, PMID 33510610, PMID 34454047, PMID 34513166, PMID 34715657, PMID 35088733, PMID 35932269, PMID 36404213, PMID 36603216, PMID 36702499, PMID 36711127, PMID 37097344, PMID 37365210, PMID 37456281, PMID 37637850, PMID 37722831, PMID 38227538, PMID 38237402, PMID 38411747

NIH funding

1UH3NS109845-01 (1), 2016 (1), 5UH3NS095553-04 (1), 5UH3NS109845-02 (1), F31NS115363 (1), P20GM130447 (1), R01DC022949 (1), R01EB006136 (1), R01NS073683 (1), R01NS075321 (1), R01NS094607 (1), R01NS097437 (1), R01NS097782 (1), R01NS125386 (1), R03DC012429 (1)